CFB
TNDM icon

Cullen/Frost Bankers’s Tandem Diabetes Care TNDM Stock Holding History

Cullen/Frost Bankers’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-135
Closed -$5.44K – 1376
2024
Q2 		$5.44K Buy
+135
New +$5.63K ﹤0.01% 937
2022
Q4 		– Sell
-5
Closed – – 1203
2022
Q3 		$0 Buy
+5
New +$274 ﹤0.01% 1204

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cullen/Frost Bankers's TNDM Position: Q3 2024 in Review

Cullen/Frost Bankers sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 135 shares — an estimated $5.44K sold.

Cullen/Frost Bankers first reported a position in TNDM in Q3 2022 and held it in 2 quarters. The position peaked at $5.44K in Q2 2024. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

  • Cullen/Frost Bankers reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
  • Cullen/Frost Bankers sold 135 Tandem Diabetes Care shares in Q3 2024, an estimated $5.44K.
  • Cullen/Frost Bankers first reported a position in Tandem Diabetes Care in Q3 2022 and held it in 2 quarters.
  • Cullen/Frost Bankers's Tandem Diabetes Care position peaked at $5.44K in Q2 2024.
  • 332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on Cullen/Frost Bankers's 13F filing for Q3 2024, filed 6 Nov 2024.